0.5017
price down icon5.38%   -0.0285
after-market Handel nachbörslich: .53 0.0283 +5.64%
loading

Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten

pulisher
Apr 24, 2025

Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK

Apr 24, 2025
pulisher
Apr 23, 2025

Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN

Apr 20, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

American Century Companies Inc. Buys 24,090 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

HC Wainwright Issues Positive Forecast for IPSC Earnings - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Acquires 39,932 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Has $3.36 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

American Century Companies Inc. Buys 1,622 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Apr 06, 2025
pulisher
Apr 05, 2025

Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

American Century Companies Inc. Purchases 31,251 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

HC Wainwright Issues Pessimistic Forecast for Century Therapeutics (NASDAQ:IPSC) Stock Price - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

H.C. Wainwright cuts Century Therapeutics target to $2 By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Sold by American Century Companies Inc. - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by American Century Companies Inc. - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Guggenheim Reiterates Buy Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

What is Chardan Capital’s Estimate for IPSC FY2025 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Century Therapeutics (NASDAQ:IPSC) Price Target Lowered to $7.00 at Chardan Capital - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair Issues Optimistic Forecast for IPSC Earnings - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Q1 EPS Estimate for Century Therapeutics Boosted by Analyst - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating - MarketScreener

Mar 24, 2025
pulisher
Mar 23, 2025

Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Guggenheim Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Piper Sandler Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00 - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Guggenheim cuts Century Therapeutics target to $5, keeps Buy rating By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

What is William Blair’s Estimate for IPSC Q3 Earnings? - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Demystifying Century Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Century Therapeutics Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2025 Conference Call for May 6, 2025 - The Manila Times

Mar 20, 2025
pulisher
Mar 19, 2025

Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Century Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

Century Therapeutics Announces Pipeline Re-Prioritization to Focus on Transformational Programs and Extends Cash Runway into Q4 2026 - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 19, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):